Applied Therapeutics, Inc. Profile Avatar - Palmy Investing

Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatmen…

Biotechnology
US, New York [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Applied Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Applied Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Applied Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of APLT's Analysis
CIK: 1697532 CUSIP: 03828A101 ISIN: US03828A1016 LEI: - UEI: -
Secondary Listings
APLT has no secondary listings inside our databases.